Microfluidic Cell Culture System for Epithelial Polarity and Barrier Function

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current in vitro epithelial cell culture methods fail to replicate the in vivo characteristics of epithelial tissues, particularly in terms of polarity, differentiation, and barrier function, limiting their use in high-throughput studies and drug screening.

Innovation Solution

A microfluidic cell culture system is used, where mesenchymal cells are introduced in the network, followed by epithelial cells, allowing them to proliferate and differentiate within a gel environment, creating a tubular structure that mimics in vivo tissue organization and morphology.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If epithelial cells are cultured on two-dimensional plastic substrata, then the culture method is simple and easy to operate, but the tissue organization and specialized differentiated cell types are lost

Engineering Contradiction:
Improveease of culture methodVSAvoidtissue organization fidelity
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The patent transitions from two-dimensional plastic substrata to three-dimensional microfluidic devices with gel-filled chambers, allowing cells to self-organize into spherical structures that better replicate in vivo tissue architecture while maintaining culturing simplicity through standardized device protocols

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Manufacturing precision

If 3D cell-culture models are used to enhance tissue organization, then morphological characteristics improve, but the structural control and apical-basal access are lost

Engineering Contradiction:
Improvetissue organization fidelityVSAvoidapical-basal access
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The microfluidic device is divided into separate apical and basal chambers filled with different gels, with the epithelial sphere positioned between them. This segmentation allows independent access to both apical and basal surfaces through separate access ports while maintaining the 3D spherical organization of the tissue

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses microfluidic channels and gel matrices as intermediaries to provide structured support for the epithelial sphere while enabling controlled access to both apical and basal surfaces through the device architecture, rather than direct contact with plastic substrata

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If organoid techniques are used to create flat polarized tissues, then apical-basal access is made possible, but leak-tight barriers are not achieved

Engineering Contradiction:
Improveapical-basal accessVSAvoidbarrier function
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent maintains the spherical organization of epithelial organoids rather than flattening them, as the spherical geometry naturally provides continuous apical-basal polarity throughout the structure while enabling leak-tight barrier formation, and microfluidic access ports provide the necessary apical-basal access

Inventive Principle:
Principle #14Spheroidality (Curvature)

4Device complexity

If static in vitro models are used, then the model is simple to construct, but trans-epithelial electrical resistance is low and permeability is high

Engineering Contradiction:
Improvemodel complexityVSAvoidbarrier function
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent introduces dynamic fluid flow through the microfluidic device, perfusing medium through the apical and basal chambers to create mechanical stress and shear forces that enhance epithelial cell differentiation and tight junction formation, thereby improving barrier function while maintaining relatively simple device construction

Inventive Principle:
Principle #15Dynamics

Data Source

PatentEP3426769B1Double tubular structures
Publication Date: 2024.09.25 MIMETAS BV
  • EP3426769B1 patent drawingFigure 1
  • EP3426769B1 patent drawingFigure 2
  • EP3426769B1 patent drawingFigure 3

AI summary

The present invention relates to a method of culturing and/or monitoring epithelial cells using a microfluidic cell culture system comprising a microfluidic channel network. In the method epithelial cells are lined, in the microfluidic cell culture system by cells of mesenchymal origin. The cells may form a tubular or tube-like structure, i.e. a.tube in a tube. The method allows for improved epithelial models suitable for a wide variety of applications, including but not limited to high-throughput screening and analysis of epithelium in health and disease.